Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression

Aldric Hama, Jacqueline Sagen

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Chronic pain symptoms, including spontaneous unevoked pain and evoked cutaneous hypersensitivity, appear following spinal cord injury (SCI). A reliable preclinical model is needed to develop effective analgesic treatments for these symptoms. A previously described rat model of SCI pain was modified and behaviorally characterized and used to test clinically available drugs. A segment of the mid-thoracic spinal cord was compressed for 60 s with a micro-vascular clip. The sensitivity of the hind paws to noxious heat (Hargreaves test), innocuous tactile (von Frey filaments), and cooling (acetone) stimuli were determined once per week beginning 1 week following spinal compression. Spinal cord compression led to long lasting hypersensitivity to stimuli, lasting for at least 12 weeks post-surgery. Systemic baclofen, gabapentin, tramadol, and morphine dose-dependently attenuated tactile hypersensitivity. No effect on tactile hypersensitivity was observed with amitriptyline, carbamazepine, rofecoxib, and diazepam. Baclofen and morphine also dose-dependently ameliorated heat hypersensitivity. In contrast, no effect on heat hypersensitivity was observed with amitriptyline, carbamazepine, diazepam and gabapentin. The current data suggest that the model can potentially differentiate those drugs with analgesic efficacy from those that do not have efficacy in SCI pain. Thus, the model may be useful for rapid screening and clinical translation of promising SCI pain therapies.

Original languageEnglish
Pages (from-to)117-128
Number of pages12
JournalBrain Research
Volume1185
Issue number1
DOIs
StatePublished - Dec 14 2007

Fingerprint

Spinal Cord Compression
Hypersensitivity
Spinal Cord Injuries
Pain
Touch
Pharmaceutical Preparations
Baclofen
Amitriptyline
Carbamazepine
Diazepam
Morphine
Analgesics
Tramadol
Acetone
Surgical Instruments
Chronic Pain
Blood Vessels
Spinal Cord
Thorax
Skin

Keywords

  • Allodynia
  • Analgesia
  • Clinical translation
  • Hyperalgesia
  • Pain
  • Spinal cord injury

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression. / Hama, Aldric; Sagen, Jacqueline.

In: Brain Research, Vol. 1185, No. 1, 14.12.2007, p. 117-128.

Research output: Contribution to journalArticle

@article{a9f39cb25f0d4346a6f6af4ff95e5982,
title = "Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression",
abstract = "Chronic pain symptoms, including spontaneous unevoked pain and evoked cutaneous hypersensitivity, appear following spinal cord injury (SCI). A reliable preclinical model is needed to develop effective analgesic treatments for these symptoms. A previously described rat model of SCI pain was modified and behaviorally characterized and used to test clinically available drugs. A segment of the mid-thoracic spinal cord was compressed for 60 s with a micro-vascular clip. The sensitivity of the hind paws to noxious heat (Hargreaves test), innocuous tactile (von Frey filaments), and cooling (acetone) stimuli were determined once per week beginning 1 week following spinal compression. Spinal cord compression led to long lasting hypersensitivity to stimuli, lasting for at least 12 weeks post-surgery. Systemic baclofen, gabapentin, tramadol, and morphine dose-dependently attenuated tactile hypersensitivity. No effect on tactile hypersensitivity was observed with amitriptyline, carbamazepine, rofecoxib, and diazepam. Baclofen and morphine also dose-dependently ameliorated heat hypersensitivity. In contrast, no effect on heat hypersensitivity was observed with amitriptyline, carbamazepine, diazepam and gabapentin. The current data suggest that the model can potentially differentiate those drugs with analgesic efficacy from those that do not have efficacy in SCI pain. Thus, the model may be useful for rapid screening and clinical translation of promising SCI pain therapies.",
keywords = "Allodynia, Analgesia, Clinical translation, Hyperalgesia, Pain, Spinal cord injury",
author = "Aldric Hama and Jacqueline Sagen",
year = "2007",
month = "12",
day = "14",
doi = "10.1016/j.brainres.2007.09.013",
language = "English",
volume = "1185",
pages = "117--128",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression

AU - Hama, Aldric

AU - Sagen, Jacqueline

PY - 2007/12/14

Y1 - 2007/12/14

N2 - Chronic pain symptoms, including spontaneous unevoked pain and evoked cutaneous hypersensitivity, appear following spinal cord injury (SCI). A reliable preclinical model is needed to develop effective analgesic treatments for these symptoms. A previously described rat model of SCI pain was modified and behaviorally characterized and used to test clinically available drugs. A segment of the mid-thoracic spinal cord was compressed for 60 s with a micro-vascular clip. The sensitivity of the hind paws to noxious heat (Hargreaves test), innocuous tactile (von Frey filaments), and cooling (acetone) stimuli were determined once per week beginning 1 week following spinal compression. Spinal cord compression led to long lasting hypersensitivity to stimuli, lasting for at least 12 weeks post-surgery. Systemic baclofen, gabapentin, tramadol, and morphine dose-dependently attenuated tactile hypersensitivity. No effect on tactile hypersensitivity was observed with amitriptyline, carbamazepine, rofecoxib, and diazepam. Baclofen and morphine also dose-dependently ameliorated heat hypersensitivity. In contrast, no effect on heat hypersensitivity was observed with amitriptyline, carbamazepine, diazepam and gabapentin. The current data suggest that the model can potentially differentiate those drugs with analgesic efficacy from those that do not have efficacy in SCI pain. Thus, the model may be useful for rapid screening and clinical translation of promising SCI pain therapies.

AB - Chronic pain symptoms, including spontaneous unevoked pain and evoked cutaneous hypersensitivity, appear following spinal cord injury (SCI). A reliable preclinical model is needed to develop effective analgesic treatments for these symptoms. A previously described rat model of SCI pain was modified and behaviorally characterized and used to test clinically available drugs. A segment of the mid-thoracic spinal cord was compressed for 60 s with a micro-vascular clip. The sensitivity of the hind paws to noxious heat (Hargreaves test), innocuous tactile (von Frey filaments), and cooling (acetone) stimuli were determined once per week beginning 1 week following spinal compression. Spinal cord compression led to long lasting hypersensitivity to stimuli, lasting for at least 12 weeks post-surgery. Systemic baclofen, gabapentin, tramadol, and morphine dose-dependently attenuated tactile hypersensitivity. No effect on tactile hypersensitivity was observed with amitriptyline, carbamazepine, rofecoxib, and diazepam. Baclofen and morphine also dose-dependently ameliorated heat hypersensitivity. In contrast, no effect on heat hypersensitivity was observed with amitriptyline, carbamazepine, diazepam and gabapentin. The current data suggest that the model can potentially differentiate those drugs with analgesic efficacy from those that do not have efficacy in SCI pain. Thus, the model may be useful for rapid screening and clinical translation of promising SCI pain therapies.

KW - Allodynia

KW - Analgesia

KW - Clinical translation

KW - Hyperalgesia

KW - Pain

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=36448959087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448959087&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2007.09.013

DO - 10.1016/j.brainres.2007.09.013

M3 - Article

VL - 1185

SP - 117

EP - 128

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -